(2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanal → HCID 131732956, compound

HRID 2172344Notes

Reaction equation

HRID 2172344 reaction equation
[O:1]=[CH:2][C@@H:3]([C@H:5]([C@@H:7]([C@@H:9]([CH2:11][OH:12])[OH:10])[OH:8])[OH:6])[OH:4].[B-:13]1([F:26])([F:25])[N+:21]2=[CH:22][CH:23]=[CH:24][C:20]2=[CH:19][C:18]2[N:14]1[CH:15]=[CH:16][CH:17]=2>CN(C)C=O>[B-:13]1([F:26])([F:25])[N+:21]2=[CH:22][CH:23]=[CH:24][C:20]2=[CH:19][C:18]2[N:14]1[CH:15]=[CH:16][CH:17]=2.[O:1]=[CH:2][C@@H:3]([C@H:5]([C@@H:7]([C@@H:9]([CH2:11][OH:12])[OH:10])[OH:8])[OH:6])[OH:4]

Participants

4

Conditions

Temperature
0 °C

Procedure

Glucose was modified with PEG-conjugated to BODIPY. BODIPY was used as a red fluorescent indicator for cell imaging. A flame dried reaction vial (2 mL) was charged with a solution of glucose-PEG-NH2 (32 mg, 0.1 mmol) and BODIPY 650/665-X (64 mg, 0.1 mmol) under argon, and the mixture was cooled in an ice bath at 0° C. Dry dimethylformamide (DMF; Aldrich, 1 mL) was added dropwise and was stirred at 0° C. for 2 h under argon. The reaction mixture was then brought to room temperature, and continuously stirred for 24 h under argon in the dark. The reaction was monitored by reverse-phase high-pressure liquid chromatography (HPLC; Waters Corporation, USA). After completion of the reaction, DMF was removed under reduced pressure and the blue residue was purified by reverse-phase flash column chromatography using a Combiflash separating system (ISCO Combiflash Companion, USA). The desired fractions were collected and lyophilized to obtain the FR-BODIPY-glucose as a bluish green solid (75 mg, 90%). The final compound was soluble in deionized (DI) water and in a mixture of ethanol and water (volume ratio=1:1). Mass spectral analysis showed a molecular ion peak of 841 (M+1). The structure of glucose-PEG-BODIPY is shown in FIG. 1 and the synthesis scheme, including the preparation of glucose-PEG-NH2, is depicted in FIG. 4.

Workup

  1. customA flame dried
  2. customreaction vial (2 mL)
  3. customwas then brought to room temperature
  4. stirringcontinuously stirred for 24 h under argon in the dark
  5. customwas removed under reduced pressure
  6. customthe blue residue was purified by reverse-phase flash column chromatography
  7. customseparating system (ISCO Combiflash Companion, USA)
  8. customThe desired fractions were collected

Sources & evidence

ORD record
ord-e56aa3dfd79146e69ea6690c86566e38
Source dataset
uspto-grants-2015_06
Patent number
US09051418B2

Reaction notes

Loading…